scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JCONREL.2008.04.024 |
P8608 | Fatcat ID | release_ws4qmiddszhynjf76mfmao75oi |
P932 | PMC publication ID | 2603624 |
P698 | PubMed publication ID | 18539355 |
P5875 | ResearchGate publication ID | 5316837 |
P50 | author | Ick Chan Kwon | Q67123705 |
P2093 | author name string | Zhonggao Gao | |
You Han Bae | |||
Kyeongsoon Park | |||
Dongin Kim | |||
Eun Seong Lee | |||
P2860 | cites work | pH-induced micelle formation of poly(histidine-co-phenylalanine)-block-poly(ethylene glycol) in aqueous media | Q46770676 |
Histidine-conjugated poly(amino acid) derivatives for the novel endosomolytic delivery carrier of doxorubicin | Q51166727 | ||
Human tumor extracellular pH as a function of blood glucose concentration | Q51596452 | ||
Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer | Q52134258 | ||
Multidrug-resistant MCF-7 cells: an identity crisis? | Q53951257 | ||
Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro. | Q54592813 | ||
Expression of TRAIL and TRAIL receptors in normal and malignant tissues | Q56876470 | ||
In vivo imaging of extracellular pH using1H MRSI | Q61703297 | ||
Extracellular pH distribution in human tumours | Q72334607 | ||
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer | Q72673347 | ||
A novel rodent mammary window of orthotopic breast cancer for intravital microscopy | Q73245873 | ||
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma | Q24685080 | ||
Targeting multidrug resistance in cancer | Q29616803 | ||
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers | Q33235069 | ||
Folate immobilized and PEGylated adenovirus for retargeting to tumor cells | Q33243609 | ||
Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors | Q33283850 | ||
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. | Q33896810 | ||
Multicellular resistance: a paradigm for clinical resistance? | Q34060947 | ||
Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters | Q34184281 | ||
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay | Q34399808 | ||
Tat-mediated delivery of heterologous proteins into cells | Q34991904 | ||
TAT peptide internalization: seeking the mechanism of entry. | Q35100881 | ||
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies | Q35817464 | ||
TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors | Q35968339 | ||
Polymer conjugates as anticancer nanomedicines | Q36561667 | ||
Tumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-histidine). | Q40083242 | ||
Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles | Q40104142 | ||
Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells | Q40154265 | ||
Super pH-sensitive multifunctional polymeric micelle | Q40442115 | ||
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. | Q40447478 | ||
Cationic TAT peptide transduction domain enters cells by macropinocytosis. | Q40470431 | ||
Physicochemical characteristics of pH-sensitive poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) mixed micelles | Q43089706 | ||
Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells | Q44273172 | ||
Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization | Q44525531 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | micelles | Q421110 |
multiple drug resistance | Q643839 | ||
P304 | page(s) | 228-236 | |
P577 | publication date | 2008-05-09 | |
P1433 | published in | Journal of Controlled Release | Q6295046 |
P1476 | title | Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance | |
P478 | volume | 129 |
Q39140757 | A Controlled‐Release Nanocarrier with Extracellular pH Value Driven Tumor Targeting and Translocation for Drug Delivery |
Q37608021 | A Micelle Self-Assembled from Doxorubicin-Arabinoxylan Conjugates with pH-Cleavable Bond for Synergistic Antitumor Therapy |
Q33855309 | A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors |
Q35799259 | A nanobuffer reporter library for fine-scale imaging and perturbation of endocytic organelles |
Q64917268 | A pH/ROS Cascade-Responsive Charge-Reversal Nanosystem with Self-Amplified Drug Release for Synergistic Oxidation-Chemotherapy. |
Q34110105 | A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. |
Q53638303 | Acid Sensitive Polymeric Micelles Combining Folate and Bioreducible Conjugate for Specific Intracellular siRNA Delivery |
Q42850228 | Acidic extracellular microenvironment and cancer |
Q93061253 | Activated Charge-Reversal Polymeric Nano-System: The Promising Strategy in Drug Delivery for Cancer Therapy |
Q38887316 | Acylsulfonamide-Functionalized Zwitterionic Gold Nanoparticles for Enhanced Cellular Uptake at Tumor pH. |
Q42813357 | Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles |
Q38766425 | Application of arteether-loaded polyurethane nanomicelles to induce immune response in breast cancer model |
Q35049783 | Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves |
Q36247616 | Beyond the imaging: Limitations of cellular uptake study in the evaluation of nanoparticles |
Q38731667 | Biodegradable Stimuli-Responsive Polymeric Micelles for Treatment of Malignancy. |
Q28079386 | CPP-Assisted Intracellular Drug Delivery, What Is Next? |
Q37955451 | Cancer nanomedicines targeting tumor extracellular pH |
Q26830028 | Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers |
Q28468315 | Chemophototherapy: An Emerging Treatment Option for Solid Tumors |
Q34481521 | Chitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapy |
Q38189091 | Classification of stimuli-responsive polymers as anticancer drug delivery systems. |
Q38016724 | Colloidal systems for drug delivery: from design to therapy |
Q37094854 | Computational Design of Oligopeptide Containing Poly(ethylene glycol) Brushes for Stimuli-Responsive Drug Delivery. |
Q57377114 | Construction of PEG-based amphiphilic brush polymers bearing hydrophobic poly(lactic acid) side chains via successive RAFT polymerization and ROP |
Q38740666 | Controlled apoptosis by a thermally toggled nanoscale amplifier of cellular uptake |
Q37383847 | Cryopreservable and tumorigenic three-dimensional tumor culture in porous poly(lactic-co-glycolic acid) microsphere |
Q36854231 | Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. |
Q30362001 | Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment. |
Q57186392 | Design strategies for chemical-stimuli-responsive programmable nanotherapeutics |
Q38067265 | Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. |
Q38438052 | Development of P22 viral capsid nanocomposites as anti-cancer drug, bortezomib (BTZ), delivery nanoplatforms. |
Q33870874 | Development of Surface-Variable Polymeric Nanoparticles for Drug Delivery to Tumors. |
Q40037002 | Digital switching of local arginine density in a genetically encoded self-assembled polypeptide nanoparticle controls cellular uptake. |
Q39125938 | Doxorubicin conjugate of poly(ethylene glycol)-block-polyphosphoester for cancer therapy |
Q37638111 | Dual Functional Mesoporous Silicon Nanoparticles Enhance the Radiosensitivity of VPA in Glioblastoma |
Q37566986 | Dual Stimuli - Dual Response Nanoassemblies Prepared from a Simple Homopolymer |
Q34432312 | Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery |
Q38556756 | Emerging antitumor applications of extracellularly reengineered polymeric nanocarriers. |
Q98771513 | Enzyme-Responsive Nanoparticles for Anti-tumor Drug Delivery |
Q30401826 | Extracellularly activatable nanocarriers for drug delivery to tumors. |
Q37444094 | Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery |
Q28486235 | Fabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumor |
Q39702507 | Finely Tuned Thermo-Responsive Block Copolymer Micelles for Photothermal Effect-Triggered Efficient Cellular Internalization |
Q39060269 | From Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers. |
Q38095361 | Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. |
Q41130277 | Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis. |
Q38997366 | Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating |
Q39300429 | Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells |
Q36612939 | Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents. |
Q41035893 | Hierarchical Targeting Strategy for Enhanced Tumor Tissue Accumulation/Retention and Cellular Internalization |
Q39197374 | Hybrid nanoparticles for drug delivery and bioimaging: Mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye |
Q37641455 | Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy |
Q39644963 | In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel |
Q38730715 | Inhibition of breast cancer metastasis by paclitaxel-loaded pH responsive poly(β-amino ester) copolymer micelles |
Q33577349 | Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers |
Q38584491 | Intracellular delivery of nanocarriers and targeting to subcellular organelles |
Q37995239 | Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application |
Q36128722 | Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes |
Q35074580 | Layer-by-Layer Nanoparticles with a pH-Sheddable Layer for in Vivo Targeting of Tumor Hypoxia |
Q39365937 | Mechanisms of Drug Resistance Reversal in Dox-Resistant MCF-7 Cells by pH-Responsive Amphiphilic Polyphosphazene Containing Diisopropylamino Side Groups |
Q39017324 | Multifunctional nanoassemblies of block copolymers for future cancer therapy |
Q35019550 | Nanomedical engineering: shaping future nanomedicines |
Q27011692 | Nanomedicine therapeutic approaches to overcome cancer drug resistance |
Q38682486 | Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment |
Q39462821 | Nanoparticle encapsulated silvercarbene complexes and their antimicrobial and anticancer properties: A perspective |
Q39022735 | Nanostructural systems developed with positive charge generation to drug delivery |
Q38018774 | Nanotechnology applied to overcome tumor drug resistance |
Q38913096 | Noncanonical amino acids to improve the pH response of pHLIP insertion at tumor acidity |
Q30368171 | Novel delivery approaches for cancer therapeutics. |
Q39436965 | Octreotide-modified and pH-triggering polymeric micelles loaded with doxorubicin for tumor targeting delivery |
Q47729137 | Ocular delivery of proteins and peptides: challenges and novel formulation approaches |
Q57368739 | Oxidation and temperature dual responsive polymers based on phenylboronic acid and N-isopropylacrylamide motifs |
Q36105465 | Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles. |
Q38047267 | Physicochemical Characteristics of Nanoparticles Affect Circulation, Biodistribution, Cellular Internalization, and Trafficking |
Q38248809 | Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles |
Q36779964 | Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation |
Q30478123 | Polymeric micelles in anticancer therapy: targeting, imaging and triggered release |
Q36225509 | Polymers for Drug Delivery Systems |
Q35023993 | Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles |
Q37649864 | Rational design of multifunctional micelles against doxorubicin-sensitive and doxorubicin-resistant MCF-7 human breast cancer cells |
Q57169642 | Recent Progress and Advances in Stimuli-Responsive Polymers for Cancer Therapy |
Q37974590 | Recent advances in stealth coating of nanoparticle drug delivery systems |
Q38658534 | Recent in vivo advances in cell-penetrating peptide-assisted drug delivery. |
Q37197375 | Recent progress in tumor pH targeting nanotechnology |
Q37984588 | Recent trends in cancer drug resistance reversal strategies using nanoparticles |
Q38101177 | Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor |
Q34075216 | Scope of nanotechnology in ovarian cancer therapeutics |
Q47374159 | Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging |
Q33794267 | Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery |
Q57371723 | Stimuli responsive polymer-based strategies for polynucleotide delivery |
Q91943306 | Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics |
Q38154805 | Stimuli-responsive nanocarriers for drug delivery. |
Q47145115 | Stimuli-responsive nanocarriers for intracellular delivery |
Q36307519 | Stimuli-responsive nanoparticles for targeting the tumor microenvironment. |
Q37986317 | Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications |
Q38062891 | Stimuli-sensitive synthetic polypeptide-based materials for drug and gene delivery |
Q37775972 | Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. |
Q37575475 | Stimulus-responsive targeted nanomicelles for effective cancer therapy |
Q38062884 | Stimulus-sensitive polymeric nanoparticles and their applications as drug and gene carriers. |
Q38602460 | Strategies to stabilize cell penetrating peptides for in vivo applications |
Q38567353 | Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors |
Q86812902 | Synthesis and characterization of multi-functional linear-dendritic block copolymer for intracellular delivery of antitumor drugs |
Q51157262 | Targeted Tumor Therapy Based on Nanodiamonds Decorated with Doxorubicin and Folic Acid |
Q64886353 | Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib. |
Q36934007 | Targeted polymeric therapeutic nanoparticles: design, development and clinical translation |
Q38928745 | Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo. |
Q92656858 | Targeting immune cells for cancer therapy |
Q38809044 | The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer |
Q53192812 | The degradation and biocompatibility of pH-sensitive biodegradable polyurethanes for intracellular multifunctional antitumor drug delivery |
Q39422705 | The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel |
Q37403035 | The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system |
Q59133567 | Tumor Microenvironment Targeted Nanotherapy |
Q37638246 | Tumor targeting of a cell penetrating peptide by fusing with a pH-sensitive histidine-glutamate co-oligopeptide |
Q39558372 | Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells |
Q36907405 | Understanding and targeting cancer stem cells: therapeutic implications and challenges |
Q34139159 | Zwitterionic chitosan derivatives for pH-sensitive stealth coating |
Q38127747 | pH- and ion-sensitive polymers for drug delivery |
Q33759748 | pH-Sensitive Micelles Self-Assembled from Amphiphilic Copolymer Brush for Delivery of Poorly Water-Soluble Drugs |
Q38168593 | pH-sensitive drug-delivery systems for tumor targeting |
Q36653608 | pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery |
Q38205583 | pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances |
Search more.